nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—ADRB1—dilated cardiomyopathy	0.401	0.543	CbGaD
Cabergoline—ADRB2—dilated cardiomyopathy	0.337	0.457	CbGaD
Cabergoline—HTR2B—cardial valve—dilated cardiomyopathy	0.0162	0.335	CbGeAlD
Cabergoline—HTR7—pulmonary artery—dilated cardiomyopathy	0.00563	0.116	CbGeAlD
Cabergoline—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.00547	0.113	CbGeAlD
Cabergoline—Hypotensive—Furosemide—dilated cardiomyopathy	0.00396	0.0448	CcSEcCtD
Cabergoline—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00351	0.0723	CbGeAlD
Cabergoline—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00341	0.0703	CbGeAlD
Cabergoline—Breast pain—Spironolactone—dilated cardiomyopathy	0.00305	0.0345	CcSEcCtD
Cabergoline—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.00246	0.0278	CcSEcCtD
Cabergoline—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00244	0.0276	CcSEcCtD
Cabergoline—DRD4—heart—dilated cardiomyopathy	0.00244	0.0503	CbGeAlD
Cabergoline—Lisuride—ADRB1—dilated cardiomyopathy	0.00176	1	CrCbGaD
Cabergoline—Gastritis—Spironolactone—dilated cardiomyopathy	0.00171	0.0193	CcSEcCtD
Cabergoline—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00167	0.0189	CcSEcCtD
Cabergoline—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00152	0.0172	CcSEcCtD
Cabergoline—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.00143	0.0294	CbGeAlD
Cabergoline—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00142	0.016	CcSEcCtD
Cabergoline—ADRB1—myocardium—dilated cardiomyopathy	0.00134	0.0277	CbGeAlD
Cabergoline—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00133	0.015	CcSEcCtD
Cabergoline—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00129	0.0146	CcSEcCtD
Cabergoline—Mental disability—Furosemide—dilated cardiomyopathy	0.00126	0.0142	CcSEcCtD
Cabergoline—Breast pain—Lisinopril—dilated cardiomyopathy	0.00124	0.0141	CcSEcCtD
Cabergoline—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00119	0.0135	CcSEcCtD
Cabergoline—Alopecia—Spironolactone—dilated cardiomyopathy	0.00118	0.0133	CcSEcCtD
Cabergoline—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00112	0.0126	CcSEcCtD
Cabergoline—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.0011	0.0124	CcSEcCtD
Cabergoline—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00108	0.0122	CcSEcCtD
Cabergoline—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00108	0.0222	CbGeAlD
Cabergoline—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00105	0.0119	CcSEcCtD
Cabergoline—Malaise—Spironolactone—dilated cardiomyopathy	0.00105	0.0119	CcSEcCtD
Cabergoline—ADRA2C—myocardium—dilated cardiomyopathy	0.00101	0.0208	CbGeAlD
Cabergoline—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000984	0.0111	CcSEcCtD
Cabergoline—Discomfort—Spironolactone—dilated cardiomyopathy	0.000978	0.0111	CcSEcCtD
Cabergoline—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000971	0.011	CcSEcCtD
Cabergoline—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000959	0.0108	CcSEcCtD
Cabergoline—Confusional state—Spironolactone—dilated cardiomyopathy	0.000956	0.0108	CcSEcCtD
Cabergoline—ADRB1—heart—dilated cardiomyopathy	0.000937	0.0193	CbGeAlD
Cabergoline—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00091	0.0103	CcSEcCtD
Cabergoline—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000901	0.0102	CcSEcCtD
Cabergoline—HTR2B—heart—dilated cardiomyopathy	0.000897	0.0185	CbGeAlD
Cabergoline—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000865	0.00978	CcSEcCtD
Cabergoline—Somnolence—Spironolactone—dilated cardiomyopathy	0.000843	0.00954	CcSEcCtD
Cabergoline—ADRB1—cardiac atrium—dilated cardiomyopathy	0.000801	0.0165	CbGeAlD
Cabergoline—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000788	0.00891	CcSEcCtD
Cabergoline—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000782	0.00884	CcSEcCtD
Cabergoline—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000782	0.00884	CcSEcCtD
Cabergoline—HTR7—heart—dilated cardiomyopathy	0.000768	0.0158	CbGeAlD
Cabergoline—Face oedema—Lisinopril—dilated cardiomyopathy	0.000761	0.0086	CcSEcCtD
Cabergoline—ADRA1A—heart—dilated cardiomyopathy	0.000741	0.0153	CbGeAlD
Cabergoline—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000738	0.00835	CcSEcCtD
Cabergoline—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000719	0.00814	CcSEcCtD
Cabergoline—ADRA2C—heart—dilated cardiomyopathy	0.000706	0.0146	CbGeAlD
Cabergoline—Visual impairment—Furosemide—dilated cardiomyopathy	0.0007	0.00792	CcSEcCtD
Cabergoline—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000699	0.00791	CcSEcCtD
Cabergoline—Gastritis—Lisinopril—dilated cardiomyopathy	0.000697	0.00789	CcSEcCtD
Cabergoline—Influenza—Lisinopril—dilated cardiomyopathy	0.000681	0.0077	CcSEcCtD
Cabergoline—Pruritus—Spironolactone—dilated cardiomyopathy	0.000671	0.00759	CcSEcCtD
Cabergoline—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000663	0.0075	CcSEcCtD
Cabergoline—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000655	0.00741	CcSEcCtD
Cabergoline—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000649	0.00734	CcSEcCtD
Cabergoline—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000649	0.00734	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000633	0.00716	CcSEcCtD
Cabergoline—Dizziness—Spironolactone—dilated cardiomyopathy	0.000627	0.0071	CcSEcCtD
Cabergoline—Flatulence—Furosemide—dilated cardiomyopathy	0.000623	0.00705	CcSEcCtD
Cabergoline—Weight increased—Lisinopril—dilated cardiomyopathy	0.00062	0.00701	CcSEcCtD
Cabergoline—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000616	0.00697	CcSEcCtD
Cabergoline—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000611	0.00691	CcSEcCtD
Cabergoline—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000608	0.00688	CcSEcCtD
Cabergoline—Depression—Lisinopril—dilated cardiomyopathy	0.000605	0.00685	CcSEcCtD
Cabergoline—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.000604	0.0124	CbGeAlD
Cabergoline—Vomiting—Spironolactone—dilated cardiomyopathy	0.000603	0.00682	CcSEcCtD
Cabergoline—Rash—Spironolactone—dilated cardiomyopathy	0.000598	0.00677	CcSEcCtD
Cabergoline—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000597	0.00676	CcSEcCtD
Cabergoline—Headache—Spironolactone—dilated cardiomyopathy	0.000594	0.00672	CcSEcCtD
Cabergoline—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00059	0.00668	CcSEcCtD
Cabergoline—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000573	0.00648	CcSEcCtD
Cabergoline—Vertigo—Furosemide—dilated cardiomyopathy	0.000568	0.00643	CcSEcCtD
Cabergoline—Nausea—Spironolactone—dilated cardiomyopathy	0.000563	0.00637	CcSEcCtD
Cabergoline—ADRA2A—heart—dilated cardiomyopathy	0.000563	0.0116	CbGeAlD
Cabergoline—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000546	0.00618	CcSEcCtD
Cabergoline—Hallucination—Lisinopril—dilated cardiomyopathy	0.000542	0.00613	CcSEcCtD
Cabergoline—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000537	0.00607	CcSEcCtD
Cabergoline—Dry mouth—Furosemide—dilated cardiomyopathy	0.000526	0.00596	CcSEcCtD
Cabergoline—Confusional state—Furosemide—dilated cardiomyopathy	0.00052	0.00589	CcSEcCtD
Cabergoline—Shock—Furosemide—dilated cardiomyopathy	0.000508	0.00574	CcSEcCtD
Cabergoline—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000499	0.00564	CcSEcCtD
Cabergoline—Anorexia—Furosemide—dilated cardiomyopathy	0.000492	0.00556	CcSEcCtD
Cabergoline—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000487	0.00551	CcSEcCtD
Cabergoline—Hypotension—Furosemide—dilated cardiomyopathy	0.000482	0.00546	CcSEcCtD
Cabergoline—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000482	0.00993	CbGeAlD
Cabergoline—Alopecia—Lisinopril—dilated cardiomyopathy	0.000482	0.00545	CcSEcCtD
Cabergoline—HTR2A—heart—dilated cardiomyopathy	0.000479	0.00987	CbGeAlD
Cabergoline—Flatulence—Lisinopril—dilated cardiomyopathy	0.000467	0.00529	CcSEcCtD
Cabergoline—Tension—Lisinopril—dilated cardiomyopathy	0.000466	0.00527	CcSEcCtD
Cabergoline—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000463	0.00524	CcSEcCtD
Cabergoline—Nervousness—Lisinopril—dilated cardiomyopathy	0.000461	0.00521	CcSEcCtD
Cabergoline—Back pain—Lisinopril—dilated cardiomyopathy	0.000459	0.00519	CcSEcCtD
Cabergoline—Somnolence—Furosemide—dilated cardiomyopathy	0.000459	0.00519	CcSEcCtD
Cabergoline—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000456	0.00516	CcSEcCtD
Cabergoline—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000449	0.00507	CcSEcCtD
Cabergoline—Fatigue—Furosemide—dilated cardiomyopathy	0.000445	0.00503	CcSEcCtD
Cabergoline—Constipation—Furosemide—dilated cardiomyopathy	0.000441	0.00499	CcSEcCtD
Cabergoline—Pain—Furosemide—dilated cardiomyopathy	0.000441	0.00499	CcSEcCtD
Cabergoline—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00044	0.00498	CcSEcCtD
Cabergoline—Malaise—Lisinopril—dilated cardiomyopathy	0.000428	0.00484	CcSEcCtD
Cabergoline—Vertigo—Lisinopril—dilated cardiomyopathy	0.000426	0.00482	CcSEcCtD
Cabergoline—Syncope—Lisinopril—dilated cardiomyopathy	0.000425	0.00481	CcSEcCtD
Cabergoline—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000425	0.00481	CcSEcCtD
Cabergoline—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000422	0.00477	CcSEcCtD
Cabergoline—Palpitations—Lisinopril—dilated cardiomyopathy	0.000419	0.00474	CcSEcCtD
Cabergoline—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000417	0.00472	CcSEcCtD
Cabergoline—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000408	0.00461	CcSEcCtD
Cabergoline—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000404	0.00457	CcSEcCtD
Cabergoline—Anxiety—Lisinopril—dilated cardiomyopathy	0.000402	0.00455	CcSEcCtD
Cabergoline—Discomfort—Lisinopril—dilated cardiomyopathy	0.000399	0.00451	CcSEcCtD
Cabergoline—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000395	0.00447	CcSEcCtD
Cabergoline—Confusional state—Lisinopril—dilated cardiomyopathy	0.00039	0.00442	CcSEcCtD
Cabergoline—Oedema—Lisinopril—dilated cardiomyopathy	0.000387	0.00438	CcSEcCtD
Cabergoline—Shock—Lisinopril—dilated cardiomyopathy	0.000381	0.00431	CcSEcCtD
Cabergoline—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00038	0.0043	CcSEcCtD
Cabergoline—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000374	0.00423	CcSEcCtD
Cabergoline—Asthenia—Furosemide—dilated cardiomyopathy	0.00037	0.00419	CcSEcCtD
Cabergoline—Anorexia—Lisinopril—dilated cardiomyopathy	0.000369	0.00418	CcSEcCtD
Cabergoline—Pruritus—Furosemide—dilated cardiomyopathy	0.000365	0.00413	CcSEcCtD
Cabergoline—Hypotension—Lisinopril—dilated cardiomyopathy	0.000362	0.00409	CcSEcCtD
Cabergoline—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000353	0.00399	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000353	0.00399	CcSEcCtD
Cabergoline—Insomnia—Lisinopril—dilated cardiomyopathy	0.00035	0.00396	CcSEcCtD
Cabergoline—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000348	0.00393	CcSEcCtD
Cabergoline—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000345	0.00391	CcSEcCtD
Cabergoline—Somnolence—Lisinopril—dilated cardiomyopathy	0.000344	0.00389	CcSEcCtD
Cabergoline—Dizziness—Furosemide—dilated cardiomyopathy	0.000341	0.00386	CcSEcCtD
Cabergoline—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000341	0.00386	CcSEcCtD
Cabergoline—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000337	0.00381	CcSEcCtD
Cabergoline—Fatigue—Lisinopril—dilated cardiomyopathy	0.000334	0.00378	CcSEcCtD
Cabergoline—Pain—Lisinopril—dilated cardiomyopathy	0.000331	0.00375	CcSEcCtD
Cabergoline—Constipation—Lisinopril—dilated cardiomyopathy	0.000331	0.00375	CcSEcCtD
Cabergoline—Vomiting—Furosemide—dilated cardiomyopathy	0.000328	0.00371	CcSEcCtD
Cabergoline—Rash—Furosemide—dilated cardiomyopathy	0.000325	0.00368	CcSEcCtD
Cabergoline—Dermatitis—Furosemide—dilated cardiomyopathy	0.000325	0.00368	CcSEcCtD
Cabergoline—Headache—Furosemide—dilated cardiomyopathy	0.000323	0.00366	CcSEcCtD
Cabergoline—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000319	0.00361	CcSEcCtD
Cabergoline—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000317	0.00358	CcSEcCtD
Cabergoline—Nausea—Furosemide—dilated cardiomyopathy	0.000307	0.00347	CcSEcCtD
Cabergoline—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000306	0.00346	CcSEcCtD
Cabergoline—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000285	0.00323	CcSEcCtD
Cabergoline—Asthenia—Lisinopril—dilated cardiomyopathy	0.000278	0.00314	CcSEcCtD
Cabergoline—Pruritus—Lisinopril—dilated cardiomyopathy	0.000274	0.0031	CcSEcCtD
Cabergoline—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000265	0.003	CcSEcCtD
Cabergoline—Dizziness—Lisinopril—dilated cardiomyopathy	0.000256	0.0029	CcSEcCtD
Cabergoline—Vomiting—Lisinopril—dilated cardiomyopathy	0.000246	0.00279	CcSEcCtD
Cabergoline—Rash—Lisinopril—dilated cardiomyopathy	0.000244	0.00276	CcSEcCtD
Cabergoline—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000244	0.00276	CcSEcCtD
Cabergoline—Headache—Lisinopril—dilated cardiomyopathy	0.000243	0.00274	CcSEcCtD
Cabergoline—Nausea—Lisinopril—dilated cardiomyopathy	0.00023	0.0026	CcSEcCtD
Cabergoline—DRD5—Signaling Pathways—RAC1—dilated cardiomyopathy	1.95e-05	0.000158	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.95e-05	0.000158	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.94e-05	0.000157	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.93e-05	0.000157	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.93e-05	0.000156	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.92e-05	0.000156	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.92e-05	0.000155	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.91e-05	0.000155	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.91e-05	0.000155	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.91e-05	0.000155	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.91e-05	0.000155	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.9e-05	0.000154	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.89e-05	0.000153	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.89e-05	0.000153	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.89e-05	0.000153	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.89e-05	0.000153	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.88e-05	0.000152	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.88e-05	0.000152	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.88e-05	0.000152	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.88e-05	0.000152	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.87e-05	0.000152	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	1.87e-05	0.000152	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.87e-05	0.000151	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—AGT—dilated cardiomyopathy	1.87e-05	0.000151	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.86e-05	0.000151	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.85e-05	0.00015	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.84e-05	0.000149	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.83e-05	0.000149	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.83e-05	0.000148	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.83e-05	0.000148	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.82e-05	0.000148	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.81e-05	0.000147	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.8e-05	0.000146	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.8e-05	0.000146	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.8e-05	0.000146	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.79e-05	0.000146	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.79e-05	0.000145	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.77e-05	0.000144	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.77e-05	0.000144	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.77e-05	0.000144	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.76e-05	0.000143	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.76e-05	0.000143	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.76e-05	0.000143	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.75e-05	0.000142	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.74e-05	0.000141	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.74e-05	0.000141	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.74e-05	0.000141	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.74e-05	0.000141	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.74e-05	0.000141	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.73e-05	0.00014	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.73e-05	0.00014	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	1.72e-05	0.000139	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.72e-05	0.000139	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.72e-05	0.000139	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	1.71e-05	0.000139	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.7e-05	0.000138	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.7e-05	0.000138	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.69e-05	0.000137	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.69e-05	0.000137	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.68e-05	0.000136	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.68e-05	0.000136	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.67e-05	0.000136	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.67e-05	0.000135	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.67e-05	0.000135	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.67e-05	0.000135	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.66e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.66e-05	0.000134	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.65e-05	0.000134	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.65e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.64e-05	0.000133	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.63e-05	0.000133	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.63e-05	0.000132	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.62e-05	0.000131	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.62e-05	0.000131	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.61e-05	0.00013	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.6e-05	0.00013	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.59e-05	0.000129	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.58e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.58e-05	0.000128	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.58e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.57e-05	0.000127	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.56e-05	0.000127	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.56e-05	0.000126	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.56e-05	0.000126	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.55e-05	0.000126	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.55e-05	0.000126	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.55e-05	0.000126	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.55e-05	0.000126	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.54e-05	0.000125	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.53e-05	0.000124	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.53e-05	0.000124	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.52e-05	0.000123	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.51e-05	0.000123	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.51e-05	0.000122	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	1.51e-05	0.000122	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.5e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.5e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.5e-05	0.000122	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.5e-05	0.000121	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.49e-05	0.000121	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.48e-05	0.00012	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.47e-05	0.000119	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.46e-05	0.000119	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.46e-05	0.000118	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.44e-05	0.000117	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	1.44e-05	0.000117	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.44e-05	0.000117	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	1.44e-05	0.000117	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.44e-05	0.000117	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.44e-05	0.000117	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.44e-05	0.000117	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.44e-05	0.000116	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.43e-05	0.000116	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.43e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.42e-05	0.000115	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.42e-05	0.000115	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.42e-05	0.000115	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	1.41e-05	0.000114	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.4e-05	0.000113	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.39e-05	0.000113	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.39e-05	0.000113	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	1.38e-05	0.000112	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.38e-05	0.000112	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	1.37e-05	0.000111	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.37e-05	0.000111	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.33e-05	0.000108	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.31e-05	0.000107	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.31e-05	0.000106	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.31e-05	0.000106	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.3e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.3e-05	0.000105	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—RAF1—dilated cardiomyopathy	1.29e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.29e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.28e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.28e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.28e-05	0.000104	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.28e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.28e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.26e-05	0.000102	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.26e-05	0.000102	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.25e-05	0.000102	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.25e-05	0.000101	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.24e-05	0.000101	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	1.24e-05	0.000101	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.23e-05	0.0001	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	1.23e-05	0.0001	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.23e-05	9.96e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	1.22e-05	9.92e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.22e-05	9.92e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.22e-05	9.86e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.21e-05	9.83e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.19e-05	9.69e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.19e-05	9.67e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.19e-05	9.66e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.18e-05	9.54e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.17e-05	9.46e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.16e-05	9.4e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.16e-05	9.37e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.15e-05	9.34e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.14e-05	9.27e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.14e-05	9.25e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.13e-05	9.16e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.13e-05	9.14e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.12e-05	9.05e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.11e-05	9.04e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.11e-05	9.02e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.11e-05	9e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.11e-05	9e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.1e-05	8.95e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.1e-05	8.92e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.09e-05	8.84e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.08e-05	8.79e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.08e-05	8.77e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.08e-05	8.75e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.07e-05	8.65e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.07e-05	8.64e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.06e-05	8.62e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.06e-05	8.6e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.06e-05	8.59e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.06e-05	8.59e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.04e-05	8.47e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.03e-05	8.36e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.01e-05	8.23e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	1e-05	8.13e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.98e-06	8.1e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	9.98e-06	8.1e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	9.92e-06	8.04e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.85e-06	7.99e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.85e-06	7.99e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.84e-06	7.98e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	9.79e-06	7.94e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.71e-06	7.88e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.7e-06	7.87e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	9.64e-06	7.82e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	9.55e-06	7.75e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	9.44e-06	7.65e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	9.36e-06	7.59e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	9.21e-06	7.47e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.12e-06	7.4e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	9.02e-06	7.31e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.98e-06	7.28e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.89e-06	7.21e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—EGFR—dilated cardiomyopathy	8.88e-06	7.2e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.78e-06	7.12e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.77e-06	7.11e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	8.6e-06	6.98e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.59e-06	6.96e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.54e-06	6.93e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	8.49e-06	6.88e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	8.49e-06	6.88e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	8.38e-06	6.79e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.31e-06	6.74e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.18e-06	6.63e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.73e-06	6.27e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	7.66e-06	6.21e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.56e-06	6.14e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.54e-06	6.11e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.42e-06	6.02e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.4e-06	6e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	7.36e-06	5.97e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.26e-06	5.89e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	7.16e-06	5.81e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	7.04e-06	5.71e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	6.84e-06	5.55e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	6.8e-06	5.52e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.75e-06	5.47e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.66e-06	5.4e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	6.55e-06	5.31e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.49e-06	5.27e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.39e-06	5.18e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.26e-06	5.07e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.25e-06	5.07e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.9e-06	4.78e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	5.82e-06	4.72e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	5.82e-06	4.72e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.81e-06	4.72e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.3e-06	4.3e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	5.25e-06	4.26e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.19e-06	4.21e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.07e-06	4.11e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	5.05e-06	4.09e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	4.91e-06	3.98e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.87e-06	3.95e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.83e-06	3.92e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.74e-06	3.84e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.45e-06	3.61e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.38e-06	3.55e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.29e-06	3.48e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.27e-06	3.46e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.99e-06	3.23e-05	CbGpPWpGaD
